Clinical trialNCT04981119RecruitingObservational

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

SponsorA2 Biotherapeutics Inc.Enrollment200CRCCancerColorectal CancerHead and Neck Squamous Cell Carcinoma HNSCCMesotheliomaMesothelioma, Malignant+11 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Eric W Ng, MD, FAAP
A2 Biotherapeutics Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Banner Health
Gilbert, Arizona, United States
Matthew Ulrickson, MD
Recruiting
Mayo Clinic Hospital
Phoenix, Arizona, United States
Antonious Hazim, MD
Recruiting
City of Hope
Duarte, California, United States
Completed
University of California San Diego
La Jolla, California, United States
Sandip Patel, MD
Recruiting
Stanford University
Palo Alto, California, United States
Wen-Kai Weng, MD
Recruiting
Ucla Medical Center
Santa Monica, California, United States
Edward Garon, MDJ. Randolph Hecht, MD
Recruiting
Mayo Clinic Jacksonville
Jacksonville, Florida, United States
Yanyan Lou, MD, PhD
Recruiting
Moffitt Cancer Center
Tampa, Florida, United States
Frederick Locke, MDKedar Kirtane, MD
Recruiting
Massachusetts General Hospital/dana Farber Cancer Institute
Boston, Massachusetts, United States
Completed
Mayo Clinic Rochester
Rochester, Minnesota, United States
Julian Molina, MD, PhDYi Lin, MD, PhD
Recruiting
Washington University
St Louis, Missouri, United States
Patrick Grierson, MD, PhD
Recruiting
Nyu Langone Medical Center
New York, New York, United States
Kristen Spencer, DO
Recruiting
the Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Jinesh Gheeya, MD, PhD
Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Cathy Eng, M.D., FACP, FASCO
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Completed
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Jennifer Specht, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 29 Oct 2021
Primary completion: 31 Dec 2028
Completion: 30 Apr 2029
Last update posted: 2 Jun 2026
Registered enrollment: 200
Registry id: NCT04981119

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.